Neurology Advisor9h
Pediatric Insomnia: The Sleep Disorder Keeping Physicians Up at Night
For pediatric insomnia, Dr Umakanth Katwa and Dr Rafael Pelayo call for a blend of clinical expertise, behavioral therapy, and empathy.
Shannyn Schroeder on MSN8h
Boost Dopamine for Self-Motivation and Stay Focused
Have you ever wondered why staying motivated feels so much harder for you than it seems to for others? If you’re a woman with ADHD, it’s not just in your head. Dopamine, the brain’s key motivator, ...
gastroenterologyadvisor9h
The Science Behind Sleep Supplements: Clinical Guidance Amidst Regulatory Concerns
While sleep supplements can be beneficial, the lack of regulation means consumers are not assured of a safe and effective product.
BuzzFeed on MSN23h
After The Fall Of Roe V Wade, We Asked Men If They'd Be Willing To Take Male Birth Control And Here's What They Said
Following the Supreme Court’s overturning Roe v. Wade, conversations about male hormonal birth control have never been more ...
Neurology Advisor9h
Labeling for ADHD Med Qelbree Updated With Lactation, Pharmacodynamic Data
The prescribing information for Qelbree (viloxazine extended-release capsules) has been updated with new pharmacodynamic and lactation data.
Hosted on MSN3h
Non-Opioid Pain Medication Journavx Gets FDA Approval
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
ConsumerAffairs10h
A new non-opioid pain medication wins Food and Drug Administration approval
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction of a first-in-class non-opioi ...
FDA approves 1st new type of pain medication in decades
ABC News' Dr. Tara Narula explains the FDA's approval of Journavx, a non-opioid medication. The bride "needed four ...